Dr. Konstantinopoulos on the Phase III Results of the JAVELIN 200 Trial in Ovarian Cancer

Dr. Konstantinopoulos on Immunotherapy in Ovarian CancerПодробнее

Dr. Ledermann on Phase III ARIEL3 Results in Ovarian CancerПодробнее

Exploratory Analyses for JAVELIN Ovarian 200 Demonstrate Potential for Immunotherapy in SubgroupsПодробнее

Episode 2: Evolution of Testing in Ovarian CancerПодробнее

The JAVELIN Bladder 100 Phase III Trial ResultsПодробнее

Dr. Swisher on the Phase III VELIA Results in Ovarian CancerПодробнее

Dr. Mirza on the Phase III NOVA Trial in Ovarian CancerПодробнее

Dr. Konstantinopoulos on Rationale for TOPACIO Trial in Ovarian CancerПодробнее

The JAVELIN Bladder 100 Phase III Trial ResultsПодробнее

Dr. Zamarin on Priming Strategies in Ovarian CancerПодробнее

Analysis of the 5-year OS findings from the ATALANTE trial in ovarian cancerПодробнее

Clinical Trial: Oregovomab for Ovarian Cancer (NCT05335993)Подробнее

NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer patientsПодробнее

Dr. Ledermann on Rationale for ARIEL3 Trial in Ovarian CancerПодробнее

Final results of avelumab and axitinib in RCC in the JAVELIN Renal 101 trialПодробнее

AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancerПодробнее

Th17-Inducing Vaccines for the Treatment of Ovarian CancerПодробнее

Emerging & Promising Clinical Trials in Ovarian Cancer: Learn the LatestПодробнее

Recurrent Ovarian Cancer: QUADRA TrialПодробнее